Top Navigation

Sentinel Lymph Node – A nuclear medicine and surgical procedure that involves injecting dye around a tumor in order to identify a single lymph node at risk for the spread of cancer. This procedure is available to patients with breast, lung and colorectal cancer and melanoma. Sentinel Lymph Node Biopsy may reduce the need for major lymph node removal surgery and dramatically increases the accuracy of determining whether a tumor has spread.

Radio Frequency Ablation (RFA) – A surgical technique that transforms high-energy radio signals into intense heat that destroys inoperable liver tumors. The procedure is similar to a microwave oven, heating the tumor from the inside out.

Surgical Insertion of Pumps – The surgical implantation of a pump to direct chemotherapy to the liver. The pump is placed under the skin and connected to the hepatic artery, which supplies liver tumors with their blood supply.

Melanoma Program – A specialized program for the diagnosis and treatment of melanoma, headed by the area's only melanoma physician expert. The latest diagnostic and treatment options include sentinel lymph node biopsy and immunotherapy in the form of vaccines, interferons and High-Dose Interleukin-2 (IL-2).

Comprehensive Breast Care Program – Our physicians are part of this second opinion and educational program available through the St. Luke's Cancer Center. Individuals who are diagnosed with breast cancer or an abnormality may seek answers or a second opinion from the program's multidisciplinary team in a single day. The team of physicians and other medical experts meet in a single location and provide a physical exam, a review of all test results and the diagnosis and a recommendation for treatment or follow up care. See Comprehensive Breast Care Program (pdf) for more information.

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) - Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is an advanced treatment only available at select cancer centers nationwide, including St. Luke’s Hospital in Bethlehem, where cancer specialists are treating patients with abdominal cancers and ovarian cancer with both the HIPEC and Intraperitoneal Chemotherapy (IPC) methods. HIPEC is done immediately following cancer surgery. During this treatment, chemotherapeutic agents are heated to 108 degrees Fahrenheit and circulated throughout the abdominal cavity for about 90 minutes so that cancerous tissue becomes even more sensitive, improving the effectiveness of the treatment. St. Luke’s Hospital is one of very few centers to offer HIPEC.

Intravenous (IV) and intraperitoneal chemotherapy (IPC) - Intravenous (IV) and intraperitoneal chemotherapy (IPC) options are available to patients with advanced ovarian cancer. Chemotherapy is administered directly to the cancer site with a catheter placed into the abdominal cavity. The catheter may be placed at the time of ovarian cancer-debulking surgery or after surgery as a separate procedure. Performed on an inpatient or outpatient basis, IPC literally bathes cancerous tissue with a powerful solution of cancer-fighting drugs.

Laparoscopic Surgery for Liver Tumors

Clinical Trials – More than 100 active prevention and treatment clinical trials are available through the St. Luke's Cancer Center. Our physicians will work with you to find the most promising cancer care available at St. Luke's or at other cancer centers.

Scheduling Surgery

If you require surgery, we will arrange for pre-admission testing and will schedule your surgical procedure. We will assist you with insurance forms and the insurance pre-certification process. Our staff will work to ensure that all paperwork and scheduling is handled smoothly and accurately.

Telephone Calls to the Office

We encourage you to call our office during business hours when a member of our staff is available to answer most of your questions. If one of our physicians must be consulted for an answer, we will get back to you as quickly as possible.

Emergencies

If an urgent medical problem or emergency arises during regular business hours, please call the office. Once you provide your name and a description of the emergency, we will respond promptly to your call. When our office is closed, our answering service will take your information and forward it to the on-call physician. Please be sure to indicate that you are calling with an emergency. If you feel that any delay could result in a life-threatening situation, call 911 or your emergency medical response team, or proceed directly to the nearest emergency room for treatment. Then, call our office as soon as possible.

About our Doctors

	Lee B. Riley, MD, PhD Medical Director, St. Luke's Cancer Center Section Chief, Surgical Oncology, St. Luke's Hospital & Health Network Received BA in chemistry at Austin College in Sherman, Texas Awarded Doctor of Philosophy (Immunology) from The University of Texas Graduate School of Biomedical Sciences in San Antonio, Texas Awarded Doctor of Medicine at The University of Texas Medical School at Houston in Houston, Texas Completed internship at The University of Texas Medical School at Houston, Hermann Hospital in Houston, Texas Post Doctoral Fellowship in surgical oncology research completed at The University of Texas, MD Anderson Hospital and Cancer Center in Houston, Texas Residency in surgery completed at The University of Texas Medical School at Houston in Houston, Texas Completed fellowship in Surgical Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania Serves as Section Chief, Surgical Oncology; Medical Director, Oncology Service Line; and Director of Surgical Research at St. Luke's Hospital - Bethlehem Campus, Bethlehem, Pennsylvania Member of many societies including: The American Association of Immunologists; Association of Community Cancer Centers; Association of Cancer Executives; American College of Surgeons - Oncology Group; American Cancer Society, Lehigh Valley Chapter, Board of Directors; Pennsylvania Medical Society; Society of Surgical Oncology Certified by the American Board of Surgery First recipient, Richard J. Torpie, MD, endowed chair in oncology Recipient 2006 Community Clinical Scientist Award, Association of Community Cancer Centers Currently conducting vaccine research for solid malignant tumors Special interests in breast cancer and melanoma
	Sanjiv S. Agarwala, MD Section Chief, Medical Oncology, St. Luke's Hospital & Health Network Earned medical degree from the University of Bombay in Bombay, India Completed general medicine internship and residency at King Edward Memorial Hospital, Bombay University, in Bombay, India and at the University of Pittsburgh, Pittsburgh, Pennsylvania Completed fellowships in oncology at Tata Memorial Cancer Center in Bombay, India, at Otago University, New Zealand and at the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania Internationally recognized investigator in the field of melanoma and immunotherapy Published a variety of therapeutic approaches to melanoma in respected peer review journals Serves on the editorial boards of several journals, including the Journal of Clinical Oncology Has led promising clinical trials of immunotherapy and targeted therapy in melanoma Presents nationally and internationally on melanoma Member of several professional organizations and scientific societies, including the American Association for Cancer Research, the American Society of Clinical Oncology, the Eastern Cooperative Oncology Group, the American Society of Head and Neck Surgery, the International Society of Biological Therapy and the European Society of Medical Oncology Certified by the American Board of Internal Medicine in Medicine, Oncology and Hematology
	Darius C. Desai, MD Associate Director, St. Luke's Cancer Center Medical Director, Family Cancer Risk Evaluation Program Earned medical degree from Jefferson Medical College in Philadelphia, Pennsylvania Completed a fellowship in surgical oncology at The Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, Ohio State University in Columbus, Ohio Research fellow in human cancer genetics at The Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, Ohio State University in Colombus, Ohio Cancer liaison for the physician program at the Bethlehem and Allentown campuses Member of the American College of Surgeons, American Society of Clinical Oncology, Society of Surgical Oncology and American Society of Breast Surgeons Publishes extensively, presents nationally and authors book chapters Special interests include gastrointestinal, endocrine and breast cancers
	Hikaru Nakajima, MD Received medical degree from Nagoya University School of Medicine in Japan Completed residency in Internal Medicine at Case Western Reserve University, St. Luke's Medical Center, in Cleveland Ohio Completed fellowship in Hematology/Medical Oncology at the University of Minnesota Board certified in Hematology, Medical Oncology and Internal Medicine Special interest in breast cancer and blood cancers
	David F. Silver, MD Section Chief, Gynecologic Oncology, St. Luke's Hospital & Health Network Fellowship in gynecologic oncology, Roswell Park Cancer Institute, Buffalo, New York Sabbatical/clerkship, Radical Pelvic Resection and Reconstruction, Leipzig Universitats Frauenklinic, Leipzig, Germany Recipient of the Galloway Gynecologic Oncology Fellowship, Memorial Sloan Kettering Cancer Institute, New York, New York Residency in Obstetrics and Gynecology, Union Memorial Hospital, Baltimore, Maryland Medical degree, Jefferson Medical College, Philadelphia, Pennsylvania Member of several professional organizations and scientific societies, including the American Medical Association, the American College of Obstetrics and Gynecology, the American Association for Cancer Research, the American Society of Clinical Oncologists, the Society of Gynecologic Oncologists, the Mid-Atlantic Gynecologic Oncology Society and the Society of Laparoscopic Surgeons Certified in Obstetrics and Gynecology, American Board of Obstetrics and Gynecology Certified in Gynecologic Oncology, American Board of Obstetrics and Gynecology Lectures both nationally and internationally on gynecologic cancers Published in numerous peer-review journals
	Roderick Quiros, MD Received medical degree from the University of Texas Medical School at Houston in Houston, Texas Completed residency in general surgery at Rush University Medical Center in Chicago, Illinois Completed fellowship in surgical oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania Member of the Society of Surgical Oncology, the American Society of Clinical Oncology and the Society of American Gastrointestinal and Endoscopic Surgeons Published in numerous medical books and peer-reviewed journals and has presented internationally Special interests include gastrointestinal, endocrine and breast cancers